 |
Top 10 Anti-Aging startups in USA
Updated: April 25, 2024 |
1
Funding: $3B
Altos Labs is working on biological reprogramming technology to essentially prolong human life
Altos Labs is working on biological reprogramming technology to essentially prolong human life
2
Funding: $1.5B
Calico is Google's research and development company whose mission is to harness advanced technologies to increase our understanding of the biology that controls lifespan. We will use that knowledge to devise interventions that enable people to lead longer and healthier lives. Executing on this mission will require an unprecedented level of interdisciplinary effort and a long-term focus for which funding is already in place.
Calico is Google's research and development company whose mission is to harness advanced technologies to increase our understanding of the biology that controls lifespan. We will use that knowledge to devise interventions that enable people to lead longer and healthier lives. Executing on this mission will require an unprecedented level of interdisciplinary effort and a long-term focus for which funding is already in place.
3
Funding: $799M
Samumed is a leader in medical research and development for tissue-level regeneration. With our platform's origins in small molecule-based Wnt pathway modulation, we develop therapeutics to address a range of degenerative diseases, regenerative medicine and oncology.
Samumed is a leader in medical research and development for tissue-level regeneration. With our platform's origins in small molecule-based Wnt pathway modulation, we develop therapeutics to address a range of degenerative diseases, regenerative medicine and oncology.
4
Funding: $400M
Celgene spinout that aims is to develop cells from placentas against blood cancers and is founded on the use of stem cells from placentas. The goal is to create therapies across autoimmune and degenerative disease, immuno-oncology, and functional regeneration.
Celgene spinout that aims is to develop cells from placentas against blood cancers and is founded on the use of stem cells from placentas. The goal is to create therapies across autoimmune and degenerative disease, immuno-oncology, and functional regeneration.
5
Funding: $340.5M
Human Longevity is the genomics-based, technology-driven company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries to revolutionize the practice of medicine.
Human Longevity is the genomics-based, technology-driven company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries to revolutionize the practice of medicine.
6
Funding: $293.9M
BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.
BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.
7
Funding: $290.6M
At UNITY, we design therapeutics that prevent, halt, or reverse diseases of aging. Our medicines are designed to lengthen healthspan, the amount of time you live in good health.
At UNITY, we design therapeutics that prevent, halt, or reverse diseases of aging. Our medicines are designed to lengthen healthspan, the amount of time you live in good health.
8
Funding: $206.8M
Life Biosciences engages in advancing longevity research and entrepreneurial solutions to improve and extend healthy lives. We bring together scientists and investors to find innovative solutions and move them from the lab to the market to benefit all people.
Life Biosciences engages in advancing longevity research and entrepreneurial solutions to improve and extend healthy lives. We bring together scientists and investors to find innovative solutions and move them from the lab to the market to benefit all people.
9
Funding: $140M
Alzheon is committed to developing innovative medicines for patients suffering from Alzheimer's disease and other neurological and psychiatric disorders. Our Alzheon’s drug development platform which comprises proprietary chemistries, robust clinical efficacy and safety datasets in patients and genetically-defined subpopulations, and the ability to optimize molecules to have the desired therapeutic attributes.
Alzheon is committed to developing innovative medicines for patients suffering from Alzheimer's disease and other neurological and psychiatric disorders. Our Alzheon’s drug development platform which comprises proprietary chemistries, robust clinical efficacy and safety datasets in patients and genetically-defined subpopulations, and the ability to optimize molecules to have the desired therapeutic attributes.
10
Funding: $115M
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. esTORbio’s lead program has demonstrated in several clinical trials, including a randomized, placebo-controlled trial, the potential to treat multiple diseases of aging for which there are no approved therapies.
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. esTORbio’s lead program has demonstrated in several clinical trials, including a randomized, placebo-controlled trial, the potential to treat multiple diseases of aging for which there are no approved therapies.
Ad
Advertise your startup
11
Funding: $99.8M
AgeX is a biotechnology company focused on the development of novel therapeutics for age-related degenerative disease.
AgeX is a biotechnology company focused on the development of novel therapeutics for age-related degenerative disease.
12
Funding: $95M
Osiris Therapeutics is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets. The company operates its business through two segments: Therapeutics and Biosurgery segment. The Therapeutics segment focuses on developing biologic stem cell drug candidates from readily available and non-controversial sources. One of its products, Stromagen was used to treat breast cancer in clinical trials.
Osiris Therapeutics is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets. The company operates its business through two segments: Therapeutics and Biosurgery segment. The Therapeutics segment focuses on developing biologic stem cell drug candidates from readily available and non-controversial sources. One of its products, Stromagen was used to treat breast cancer in clinical trials.
13
Funding: $71.2M
Your health starts with your cells. Deliver wellness to every cell with the world’s first cellular health supplement.
Your health starts with your cells. Deliver wellness to every cell with the world’s first cellular health supplement.
14
Funding: $50M
Alkahest is developing therapies derived from blood and its components with a focus to improve vitality and function into old age. We are working on treatments for diseases of aging, with an emphasis on cognitive dysfunction and dementia, which are key medical challenges of our generation.
Alkahest is developing therapies derived from blood and its components with a focus to improve vitality and function into old age. We are working on treatments for diseases of aging, with an emphasis on cognitive dysfunction and dementia, which are key medical challenges of our generation.
15
Funding: $49.2M
Elevian develops medicines that restore youthful regenerative capacity, with the potential to treat and prevent age-related disease.
Elevian develops medicines that restore youthful regenerative capacity, with the potential to treat and prevent age-related disease.
17
Funding: $36M
Neuraly is a Johns Hopkins School of Medicine spinoff biotech company and aims to introduce the first, disease-modifying agent for neurodegenerative disorders and aging.
Neuraly is a Johns Hopkins School of Medicine spinoff biotech company and aims to introduce the first, disease-modifying agent for neurodegenerative disorders and aging.
18
Funding: $27M
Empowering exercise programs designed just for you, so you can chase the life you want at any age.
Empowering exercise programs designed just for you, so you can chase the life you want at any age.
20
Funding: $15.5M
Longevica is a science-driven company with a mission to find mechanisms of life extension.
Longevica is a science-driven company with a mission to find mechanisms of life extension.
21
Bioquark, Inc. is a life sciences company developing proprietary combinatorial biologic products for both the regeneration and repair of human organs and tissues. The company’s core program is focused on the development of novel combinatorial biologics capable of directly remodeling diseased, damaged, or aged tissues, creating micro-environments that induce efficient and controllable regeneration and repair.
22
Funding: $13.5M
Edifice Health is revolutionizing the way we measure inflammation and immune health with a novel artificial intelligence-based technology to help you change the course of your aging process.
Edifice Health is revolutionizing the way we measure inflammation and immune health with a novel artificial intelligence-based technology to help you change the course of your aging process.
23
TDx is a molecular diagnostic and precision medicine company focused on developing clinically useful lab tests that guide treatment decisions for better outcomes initially in oncology.
24
Funding: $7.1M
Oisín Biotechnologies' ground-breaking research and technology is demonstrating that the solution to mitigating the effects of age-related diseases is to address the damage created by the aging process itself.
Oisín Biotechnologies' ground-breaking research and technology is demonstrating that the solution to mitigating the effects of age-related diseases is to address the damage created by the aging process itself.
25
Funding: $4m
AgelessRx is a telehealth e-commerce startup offering prescriptions for longevity-promoting treatments.
AgelessRx is a telehealth e-commerce startup offering prescriptions for longevity-promoting treatments.
26
Turn.bio is developing therapies to effectively return mature differentiated cells to a dramatically younger state
27
Funding: $250K
We focus on cellular aging as this is the leading risk factor for most major pathology. We are developing therapies to regenerate muscle and tissue. We believe everyone has the right to access therapies.
We focus on cellular aging as this is the leading risk factor for most major pathology. We are developing therapies to regenerate muscle and tissue. We believe everyone has the right to access therapies.
28
LGT develops telomerase therapy (hTERT gene therapy) that cures Alzheimer’s disease and aging
29
Deep Longevity is a biotechnology company transforming longevity R&D through AI-discovered biomarkers of aging.
